Taysha Gene Therapies, Inc. — DEF 14A Filings
6 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Taysha Gene Therapies, Inc. (TSHA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Taysha Gene Therapies, Inc. has filed 6 DEF 14A documents with the SEC since 2020. To view all SEC filings by Taysha Gene Therapies, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-25-087214 | Apr 21, 2025 | Jun 2, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-100792 | Apr 18, 2024 | May 29, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-251065 | Oct 5, 2023 | Nov 15, 2023 |
| DEF 14A | DEF 14A | 0001193125-23-138221 | May 8, 2023 | Jun 22, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-127828 | Apr 28, 2022 | Jun 17, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-140758 | Apr 29, 2021 | Jun 17, 2021 |